{
    "clinical_study": {
        "@rank": "65350", 
        "acronym": "PORCH", 
        "arm_group": {
            "arm_group_label": "Bladder Cancer Patients", 
            "description": "Patients diagnoses with bladder cancer who are eligible to undergo treatment."
        }, 
        "biospec_descr": {
            "textblock": "Whole blood samples"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to create a registry of older patients undergoing surgical\n      and/or medical treatment for bladder cancer. The registry will record side-effect and\n      outcomes related to the treatment using different surveys and biological measures."
        }, 
        "brief_title": "Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer", 
        "completion_date": {
            "#text": "April 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Bladder Cancer", 
        "condition_browse": {
            "mesh_term": "Urinary Bladder Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "The primary purpose of this protocol is to create a registry of elderly patients with\n      high-risk invasive bladder cancer undergoing radical cystectomy with or without preoperative\n      chemotherapy.\n\n      Secondary objectives will include an exploration of the association between functional\n      status, surgical complications, and laboratory markers with complications and survival.  In\n      addition, exploratory analyses may evaluate the association of expression of the senescence\n      marker p16INK4a and the morbidity and mortality associated with treatment.\n\n      Patients will be asked to complete a Geriatric Assessment (GA) and FACT-Bl serially over the\n      course of the study in order to evaluate their functional status and quality of life during\n      the course of treatment.  Additionally, complications will be tracked in an inpatient and\n      outpatient setting using the Memorial Sloan Kettering Cancer Center (MSKCC) complications\n      grading system."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with a known pathologic diagnosis of lower tract urothelial carcinoma who\n             are eligible to undergo radical cystectomy with or without neoadjuvant chemotherapy\n             for definitive diagnosis and treatment.\n\n          -  Signed, IRB approved written informed consent.\n\n          -  Completion of baseline Geriatric Assessment\n\n        Exclusion Criteria:\n\n          -  Inability to read and speak English\n\n          -  Inability to comply with study for any other reason than language\n\n          -  Dementia, altered mental status, or any psychiatric condition that would prohibit the\n             understanding or rendering of informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with a known pathologic diagnosis of lower tract urothelial carcinoma who are\n        eligible to undergo radical cystectomy with or without neoadjuvant chemotherapy for\n        definitive diagnosis and treatment."
            }
        }, 
        "enrollment": {
            "#text": "25", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 20, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01776138", 
            "org_study_id": "LCCC1206", 
            "secondary_id": "12-0577"
        }, 
        "intervention": {
            "arm_group_label": "Bladder Cancer Patients", 
            "intervention_name": "Collect Blood and Survey Instruments", 
            "intervention_type": "Other", 
            "other_name": [
                "p16 Blood Collection", 
                "Geriatric Assessment", 
                "Fact-BL", 
                "Health Behavior Questionnaire"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Elderly", 
            "Chemotherapy", 
            "Cystectomy", 
            "Radical Cystectomy", 
            "University of North Carolina", 
            "Cancer", 
            "Bladder Cancer", 
            "Bladder"
        ], 
        "lastchanged_date": "February 26, 2014", 
        "location": {
            "contact": {
                "email": "shani_alston@med.unc.edu", 
                "last_name": "Shani Alston, MPH", 
                "phone": "919-843-1906"
            }, 
            "facility": {
                "address": {
                    "city": "Chapell Hill", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27514"
                }, 
                "name": "UNC Lineberger Comprehensive Cancer Center"
            }, 
            "investigator": [
                {
                    "last_name": "Angela Smith, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Hyman Muss, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "PORCH: A Registry of Prospective Outcomes of Radical Cystectomy With or Without Chemotherapy", 
        "overall_contact": {
            "email": "shani_alston@med.unc.edu", 
            "last_name": "Shani M Alston, MPH", 
            "phone": "919-843-1906"
        }, 
        "overall_official": {
            "affiliation": "University of North Carolina Lineberger Comprehensive Cancer Center", 
            "last_name": "Angela Smith, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To collect the number of changes in functional status, surgical complications, and survival in patients with urothelial carcinoma of the bladder following radical cystectomy with or without neoadjuvant chemotherapy in a prospective database (to be called the PORCH database- \"Prospective Outcomes of Radical cystectomy with or without Chemotherapy\").", 
            "measure": "To collect the number of changes in functional status, surgical complications and survival status collected in a prospective database of patients undergoing a radical cystectomy with or without chemotherapy", 
            "safety_issue": "No", 
            "time_frame": "1 Year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01776138"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Measure the association of all baseline measures with the outcomes of complications post-surgery and 90 day mortality for the 25 patients entered into the database who complete the GA and FACT-Bl questionnaires.", 
                "measure": "To measure associations between baseline measures with post-surgery and 90 day outcome measures", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }, 
            {
                "measure": "To count changes over the course of treatment for components of the GA, the FACT-Bl, p16, and other clinical characteristics.", 
                "safety_issue": "No", 
                "time_frame": "2 years"
            }
        ], 
        "source": "UNC Lineberger Comprehensive Cancer Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "UNC Lineberger Comprehensive Cancer Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2014"
    }
}